Skip to main content
. 2020 May 22;158(4):1526–1534. doi: 10.1016/j.chest.2020.04.066

Figure 3.

Figure 3

Transplant-free survival in antifibrotic-treated patients with idiopathic pulmonary fibrosis stratified by clinical-molecular signature classification in derivation (A) and validation (B) cohorts.